Cargando…

Biomarker panels associated with progression of renal disease in type 1 diabetes

AIMS/HYPOTHESIS: We aimed to identify a sparse panel of biomarkers for improving the prediction of renal disease progression in type 1 diabetes. METHODS: We considered 859 individuals recruited from the Scottish Diabetes Research Network Type 1 Bioresource (SDRNT1BIO) and 315 individuals from the Fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colombo, Marco, Valo, Erkka, McGurnaghan, Stuart J., Sandholm, Niina, Blackbourn, Luke A. K., Dalton, R. Neil, Dunger, David, Groop, Per-Henrik, McKeigue, Paul M., Forsblom, Carol, Colhoun, Helen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677704/ https://www.ncbi.nlm.nih.gov/pubmed/31222504 http://dx.doi.org/10.1007/s00125-019-4915-0

Ejemplares similares

Effect of serum sample storage temperature on metabolomic and proteomic biomarkers
por: Valo, Erkka, et al.
Publicado: (2022)

Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes
por: Colombo, Marco, et al.
Publicado: (2020)

Microvascular disease in diabetes and severe COVID-19 outcomes – Authors' reply
por: Colhoun, Helen M, et al.
Publicado: (2021)

Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
por: Sandholm, Niina, et al.
Publicado: (2018)

Rate of Kidney Function Decline is Associated With Kidney and Heart Failure in Individuals With Type 1 Diabetes
por: Sandholm, Niina, et al.
Publicado: (2023)

Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the “omnigenic” sparse effector hypothesis of complex trait genetics
por: Iakovliev, Andrii, et al.
Publicado: (2023)

Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes
por: Mutter, Stefan, et al.
Publicado: (2021)

Development and validation of a cardiovascular risk prediction model in type 1 diabetes
por: McGurnaghan, Stuart J., et al.
Publicado: (2021)

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study
por: Ochs, Andreas, et al.
Publicado: (2019)

Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
por: Pongrac Barlovic, Drazenka, et al.
Publicado: (2020)

Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations
por: Sandholm, Niina, et al.
Publicado: (2022)

Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status
por: Parente, Erika B., et al.
Publicado: (2020)

Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus
por: Colombo, Marco, et al.
Publicado: (2019)

Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
por: Mair, Colette, et al.
Publicado: (2019)

Flash monitor initiation is associated with improvements in HbA(1c) levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study
por: Jeyam, Anita, et al.
Publicado: (2021)

The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
por: Höhn, Andreas, et al.
Publicado: (2021)

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study
por: Bell, Samira, et al.
Publicado: (2017)

Serum kidney injury molecule 1 and β(2)-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes
por: Colombo, Marco, et al.
Publicado: (2018)

Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes
por: Haukka, Jani K., et al.
Publicado: (2018)

Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes
por: Härma, Mari-Anne, et al.
Publicado: (2020)

Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017
por: O’Reilly, Joseph E., et al.
Publicado: (2020)

Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland
por: McGurnaghan, Stuart J., et al.
Publicado: (2022)

Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013–2018
por: Höhn, Andreas, et al.
Publicado: (2022)

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes
por: McKeigue, Paul M., et al.
Publicado: (2019)

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis
por: McGurnaghan, S., et al.
Publicado: (2018)

Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland
por: Jeyam, Anita, et al.
Publicado: (2021)

Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes
por: Wadén, Jenny M., et al.
Publicado: (2019)

Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study
por: McKeigue, Paul M., et al.
Publicado: (2020)

Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
por: McKeigue, Paul M., et al.
Publicado: (2021)

Genetic and epigenetic background of diabetic kidney disease
por: Sandholm, Niina, et al.
Publicado: (2023)

Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study
por: Vadiveloo, Thenmalar, et al.
Publicado: (2018)

Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes
por: Syreeni, Anna, et al.
Publicado: (2019)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes
por: Syreeni, Anna, et al.
Publicado: (2011)

Medication profiling in women with type 1 diabetes highlights the importance of adequate, guideline-based treatment in low-risk groups
por: Lithovius, Raija, et al.
Publicado: (2023)

Mapping activities on climate and health to the essential public health operations (EPHO)
por: McGurnaghan, P, et al.
Publicado: (2023)

Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study
por: Harjutsalo, Valma, et al.
Publicado: (2011)

Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
por: McKeigue, Paul M, et al.
Publicado: (2022)

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
por: McGurnaghan, Stuart J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lqrcjque38j4a2152knarqp94d